Top Transportation Companies To Watch In Right Now

With shares of General Electric (NYSE:GE) trading around $27, is GE an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

General Electric is a diversified industrial, technology, and financial services company that operates worldwide. The products and services of the company range from aircraft engines, power generation, water processing, and household appliances to medical imaging, business and consumer financing, and industrial products. General Electric�� segments are Energy Infrastructure, Aviation, Healthcare, Transportation, Home & Business Solutions, and GE Capital. General Electric is a leading provider of a wide range of products and many are essential in daily lives of consumers and companies around the world.

General Electric is also benefiting from Boeing�� huge 777X orders as GE makes the engines that power the aircraft. According to a press release from the company, General Electric received a record $26 billion in orders for its new GE9X jet engine at the Dubai Airshow. Emirates accounted for $11 billion of that figure alone. The company says the new engine ��ill be the largest and most fuel efficient engine GE has ever designed and manufactured and the rising number of orders for the engine-aircraft combination serve as a testament to the confidence our customers have in the product.��/p>

Best Machinery Companies To Own In Right Now: Ryanair (RYAAY)

Ryanair Holdings plc (Ryanair Holdings), incorporated in 1996, is a holding company for Ryanair Limited (Ryanair). Ryanair operates a low-cost, scheduled-passenger airline serving short-haul, point-to-point routes between Ireland, the United Kingdom, Continental Europe, and Morocco. As of June 30, 2012, the Company offered approximately over 1,500 scheduled short-haul flights per day serving approximately 160 airports largely throughout Europe with an operating fleet of 294 aircraft flying approximately 1,500 routes. Ryanair sells seats on a one-way basis. The Company also holds a 29.8% interest in Aer Lingus Group plc. As of June 30, 2012, Ryanair�� operating fleet was composed of 294 Boeing 737-800 aircraft, each having 189 seats. Ryanair�� fleet totaled 294 Boeing 737-800s at March 31, 2012. As of June 30, 2012, Ryanair owned and operated four Boeing 737-800 full flight simulators for pilot training. Ryanair provides ancillary services and engages in other activities connected with its core air passenger service, including non-flight scheduled services, Internet-related services, and the in-flight sale of beverages, food, and merchandise. As part of its non-flight scheduled and Internet-related services Ryanair incentivizes ground service providers at airports it serves to levy correct excess baggage charges for any baggage, which exceeds Ryanair�� published baggage allowances. Excess baggage charges are recorded as non-flight scheduled revenue. Ryanair distributes accommodation services and travel insurance through its Website. For hotel services, Ryanair has a contract with Hotelscombined PTY Ltd. (Hotelscombined), which operates a price comparison Website, pursuant to which Hotelscombined handles all aspects of such services marketed through Ryanair�� Website and pays a fee to Ryanair. Ryanair also has contracts with other accommodation providers that enable Ryanair to offer hostel, bed-and-breakfast, guesthouse, villa and apartment accommodation to its customers. In addition Ryanair has a contract with Hertz, pursuant to which Hertz handles all car rental services marketed through Ryanair�� Website or telephone reservation system. Ryanair also sells bus and rail tickets onboard its aircraft and through its Website. Ryanair also sells attractions and activities on its Website. Ryanair sells gift vouchers on its Website, which are also redeemable online. The Company has an contract with Webloyalty International Ltd, which offers Ryanair�� customers who have a United Kingdom, German or French billing address a retail discount and cash-back program. Ryanair has agreements, pursuant to which the Company promotes Ryanair-branded credit cards issued by MBNA, GE Money, Access Prepaid and Banco Santander on its Internet site. The MBNA agreement relates to Irish residents only, the GE Money agreement relates to Swedish and Polish residents only and the Banco Santander agreement relates to United Kingdom residents only. During the fiscal year ended March 31, 2012, Ryanair rolled out handheld Electronic Point of Sale (EPOS) devices across its route network. These EPOS devices replaced manual and paper based systems on board the aircraft. The EPOS device enables cabin crew to sell and record their on-board sales transactions. The EPOS device also issues bus and rail tickets and tickets for tourist attractions. The Company also offers reserved seating in twenty-one extra legroom seats on each aircraft for a fee on certain routes. Ryanair provides its own aircraft and passenger handling and ticketing services at Dublin Airport. Third parties provide these services to Ryanair at other airports it serves. Servisair plc provides Ryanair�� ticketing, passenger and aircraft handling, and ground handling services at airports in Ireland and the United Kingdom(excluding London (Stansted) Airport where these services are provided by Swissport Ltd.), while similar services in continental Europe are provided by the local airport authorities, either directly or through sub-contractors. Advisors' Opinion:

• [By GURUFOCUS]

  In the world of publicly-owned businesses, we try to invest with the same sort of individuals. In our opinion, Michael O'Leary, Ryanair's Chairman and CEO, is one such example of a talented, driven executive. Michael was born on a farm in Ireland, the second oldest of six siblings. Although his beginnings were not remarkable, Michael figured out how to get the best education he could by attending the best schools he could. After attending a Jesuit boarding school as a young boy, he graduated from Trinity College with an accounting degree; began his career working for KPMG, a large public accounting firm; and, soon afterwards, became a financial advisor to Tony Ryan, Ryanair's founder. In 1986, Michael was hired to work for Ryan and initially advised him to close the airline immediately since it was losing so much money! In 1989, when Ryanair (RYAAY) was on the brink of insolvency, Ryan offered Michael the job of Deputy CEO of the airline and in 1994 as its CEO. Michael accepted, on the condition that if he couldn't make it profitable, he would be allowed to shut it down! He also chose to work for a percentage of profits rather than for a salary from the money losing business.

Top Transportation Companies To Watch In Right Now: GasLog Ltd (GLOG)

GasLog Ltd. (GasLog), incorporated on July 16, 2003, is an owner, operator and manager of liquefied natural gas (LNG) carriers. The Company is a holding company. Its subsidiaries conduct all of its operations and own all of its operating assets, including its ships. The Company operates in two segments: vessel ownership and vessel management. In the vessel ownership segment, the services provided primarily consist of chartering out company-owned LNG carriers, and in the vessel management segment the services provided consist of LNG carrier technical management services, as well as LNG carrier construction supervision services and other vessel management services provided to the Company�� vessel ownership segment and to external third parties.

In February 2011, GasLog Carriers Ltd. established two vessel-owning companies, GAS-five Ltd. and GAS-six Ltd. In March 2011, GasLog Carriers Ltd. established two vessel-owning companies, GAS-seven Ltd. and GAS-eight Ltd. In June 2011, GasLog Carriers Ltd. established two additional vessel-owning companies, GAS-nine Ltd. and GAS-ten Ltd. In June 2011, Ceres Shipping Ltd. (Ceres Shipping) transferred its interest in GasLog Ltd. to Blenheim Holdings Ltd. (Blenheim Holdings). In June 2011, an entity jointly owned by the Livanos and Radziwill families (Joint Venture Partner) sold its 49% interest in GAS-three Ltd., GAS-four Ltd., GAS-five Ltd. and GAS-six Ltd. to Ceres Shipping. Ceres Shipping contributed the 49% interest in GAS-three Ltd., GAS-four Ltd., GAS-five Ltd. and GAS-six Ltd. to Blenheim Holdings, who in turn contributed the 49% interest in these four vessel-owning companies to GasLog Ltd., which contributed the same to GasLog Carriers Ltd. As of December 31, 2011, the Company owned 100% interest in GAS-three Ltd., GAS-four Ltd., GAS-five Ltd. and GAS-six Ltd. On July 11, 2011 and September 5, 2011, the Company transferred its interest of two dormant subsidiaries, GasLog Holdings Limited and GasLog Services Limited, respectively, to Ceres Shi! pping.

As of December 31, 2011, the Company�� owned fleet consisted of 10 wholly owned LNG carriers. As of December 31, 2011, the Company managed and operated 14 LNG carriers, which included its owned ships, as well as 11 ships owned or leased by BG Group plc (BG Group), a participant in the worldwide energy and natural gas markets, and one additional LNG carrier in which it had a 25% interest. As of December 31, 2011, the Company owned a 25% interest in Egypt LNG Shipping Ltd. (Egypt LNG), whose principal asset is the LNG carrier Methane Nile Eagle. The Company�� owned fleet includes the GasLog Savannah, the GasLog Singapore, four LNG carriers on order at Samsung Heavy Industries Co., Ltd. (Samsung Heavy Industries) in South Korea, two LNG carriers on order at Samsung Heavy Industries in South Korea, and two LNG carriers on order at Samsung Heavy Industries in South Korea.

The Company�� wholly owned subsidiary, GasLog LNG Services Ltd., (GasLog LNG Services) handles the technical management of its fleet. Through GasLog LNG Services, it provides technical ship management services for 12 LNG carriers owned by third parties in addition to management of the two LNG carriers operating in its owned fleet. The Company provides the services of its owned ships under time charters. The Company�� subsidiaries include GasLog Investments Ltd., GasLog Monaco S.A.M., Ceres LNG Employee Incentive Scheme Ltd., GasLog Carriers Ltd., GAS-one Ltd., GAS-two Ltd., GAS-three Ltd., GAS-four Ltd., GasLog Shipping Company Ltd., GasLog Shipping Limited and Egypt LNG Shipping Ltd.

Advisors' Opinion:

• [By Rebecca McClay]

  And, GasLog Ltd. (NYSE: GLOG) is up 2.4% after it announced it has signed a memorandum of agreement to acquire the STX Frontier, a 153,600 cubic meter liquefied natural gas (LNG) carrier, from Singapore-based STX Pan Ocean LNG PTE. Ltd. The acquisition cost of the vessel is in the vicinity of US$160 million.

• [By Stephen Quickel]

  Gaslog Limited (GLOG)

  This Monaco-based company owns and operates a sizeable fleet of ocean-going liquefied natural gas (LNG) carriers, which it charters out and manages for others. Earnings are expected to grow 32% a year. Thirteen of 14 analysts rate it a Strong Buy or Buy.

• [By Robert Rapier]

  GasLog (NYSE: GLOG) owns 15 LNG carriers, with eight ships on the water and seven more to be delivered by 2016. The company is one that we have liked and recommended, and it performed well in 2013, up 33 percent for the year. It has long been thought that the company might drop down assets into an MLP, but last week’s news that this will indeed be the case helped propel the stock up nearly 20 percent for the week.

Top Transportation Companies To Watch In Right Now: Pembina Pipeline Corp (PBA)

Pembina Pipeline Corporation (Pembina) is a Calgary-based company, engaged in providing transportation and midstream services. It owns and operates: pipelines that transport conventional and synthetic crude oil and natural gas liquids produced in western Canada; oil sands, heavy oil and diluent pipelines; gas gathering and processing facilities; and, an oil and natural gas liquids infrastructure and logistics business. It has facilities located in western Canada and in natural gas liquids markets in eastern Canada and the United States. Pembina also offers a spectrum of midstream and marketing services. Pembina�� Midstream business is organized into two segments: crude oil and NGL. The crude oil segment represents the Company�� midstream operations. The NGL segment includes two operating systems: Redwater West and Empress East. Pembina's Conventional Pipelines business consists of a pipeline network, located 7,850 kilometers, that extends across much of Alberta and British Columbia. Advisors' Opinion:

• [By Vanin Aegea]

  Two companies that have been around for some time now are Imperial Oil (IMO) and Pembina Pipeline (PBA). Political instability in the Middle East has also given an extra relevance to the reserves found at this region, so let us see what the future holds and what gurus think of them.

• [By Rich Duprey]

  Midstream operator�Pembina Pipeline� (NYSE: PBA  ) �announced yesterday its monthly dividend for May of $0.135 per share,�which is designated an "eligible dividend" for Canadian income tax purposes. For non-resident shareholders, Pembina's dividends are considered "qualified dividends" and are subject to Canadian withholding tax.

• [By Rich Duprey]

  Midstream operator Pembina Pipeline (NYSE: PBA  ) announced yesterday its monthly dividend for July, of $0.135 per share, which is designated an "eligible dividend" for Canadian income tax purposes. For non-resident shareholders, Pembina's dividends are considered "qualified dividends," subject to Canada's withholding tax.

Top Transportation Companies To Watch In Right Now: Norfolk Souther Corporation(NSC)

Norfolk Southern Corporation, through its subsidiaries, engages in the rail transportation of raw materials, intermediate products, and finished goods primarily in the United States. The company transports coal products, such as coal, coke, and iron ore; automotive products, including finished vehicles and auto parts; chemicals products consisting of sulfur and related chemicals, petroleum products, chlorine and bleaching compounds, plastics, rubber, industrial chemicals, chemical wastes, and municipal wastes; metals and construction products comprising steel, aluminum products, machinery, scrap metals, cement, aggregates, bricks, and minerals; and paper, clay, and forest products, including lumber and wood products, pulp board and paper products, wood fibers, wood pulp, scrap paper, and clay. It also transports agriculture, consumer, and government products, such as soybeans, wheat, corn, fertilizer, animal and poultry feed, food oils, flour, beverages, canned goods, swee teners, consumer products, ethanol, and items for the military. In addition, it engages in the intermodal operations that include moving of shipments in trailers, the United States and international containers, and roadrailer equipment. Further, the company transports overseas freight through various Atlantic and Gulf Coast ports, as well as provides a range of logistics services; and operates passenger and commuter trains. Additionally, it involves in the acquisition, leasing, and management of coal, oil, gas, and minerals; the development of commercial real estate; telecommunications; and the leasing or sale of rail property and equipment. As of December 31, 2010, the company operated approximately 20,000 route miles in 22 states and the District of Columbia. The company was founded in 1883 and is based in Norfolk, Virginia.

Advisors' Opinion:

• [By Lauren Pollock]

  Norfolk Southern Corp.(NSC) said its fourth-quarter earnings rose 24% as strength in the railroad operator’s general merchandise and intermodal units offset continued weak coal demand. Results beat expectations, pushing shares up 3.6% to $91.88 premarket.

• [By Geoff Gannon] Hewlett-Packard and Value Line?

  Well, Value Line is obviously too small an investment for Buffett. But we��e using it as a stand in for all the publishers Buffett once loved but now shuns.

  Buffett is a return on investment investor. He isn�� exactly a growth investor or a value investor ��if by growth we mean total revenue growth and if by value we mean the company�� value as of today.

  Buffett wants to compound his money at the fastest rate possible. So he looks at how much of the company�� sales, assets, etc. he is getting. Basically, he looks at a price ratio. And then he looks into the company�� return on its own sales, assets, etc. When you take those two numbers together you get something very close to a rate of return.

  The last part you need to consider is the change in assets versus the change in sales (and earnings). Does the company need to grow assets faster than earnings?

  Or ��like See�� Candy ��can it grow sales a little faster than assets?

  Let�� take a look at Norfolk Southern as a good example of the kind of railroad Buffett would own ��if he didn�� own all of Burlington Northern.

  Norfolk Southern

  10-Year Average Return on Assets: 4.9%

  10-Year Annual Sales Growth: 6.0%

  10-Year Annual Asset Growth: 3.6%

  Now, how much earning power do you get when you invest in Norfolk Southern?

  Total Assets are $28.54 billion. And the market cap is $21.28 billion. So, $28.54 billion / $21.28 billion = $1.34 in assets for every $1 you pay for the stock today.

  Now, Norfolk Southern�� return on assets has averaged a little less than 5% over the last decade. But I think that ��like he does with IBM ��Buffett believes the current returns on assets of the railroads are sustainable. So, we are talking something in the 5% to 7% range for a railroad like Norfolk Southern.

  On top of this, he sees that the railroads have grown sales faster than assets. Now, we could do

Top Transportation Companies To Watch In Right Now: EQT Midstream Partners LP (EQM)

EQT Midstream Partners, LP owns, operates, acquires and develops midstream assets in the Appalachian Basin. The Company provides substantially all of its natural gas transmission, storage and gathering services under contracts with fixed reservation and/or usage fees. The Company focuses its operations in the Marcellus Shale fairway in southern Pennsylvania and northern West Virginia. It provides midstream services to EQT Corporation in the Appalachian Basin across 22 counties in Pennsylvania and West Virginia through its two primary assets: its transmission and storage system, which serves as a header system transmission pipeline, and its gathering system, which delivers natural gas from wells and other receipt points to transmission pipelines.

Equitrans Transmission and Storage System

As of December 31, 2011, the Company�� transmission and storage system included an approximately 700 mile FERC-regulated interstate pipeline system that connects to five interstate pipelines and multiple distribution companies, and it is supported by 14 associated natural gas storage reservoirs with approximately 400 million cubic feet per day of peak withdrawal capability and 32 billion cubic feet of working gas capacity. As of December 31, 2011, its transmission assets had total throughput capacity of approximately 1.0 trillion British thermal units per day.

Equitrans Gathering System

The Company�� gathering system consists of approximately 2,100 miles of FERC-regulated low-pressure gathering lines that have multiple delivery interconnects with its transmission and storage system and a gathering and interstate pipeline system owned and operated by Dominion Transmission, Inc.

Advisors' Opinion:

• [By Matt DiLallo]

  Unfortunately for XTO Energy, there was one small and, unbeknownst to anyone, unresolved matter. You see, LINN had a contract to sell its gas through a unit of Dominion Resources (NYSE: D  ) , which was gathering the gas in its system. However, LINN's gas wasn't up to the system's standards, so it began to look for another gatherer and it approached Equitrans, which is now part of EQT Midstream Partners (NYSE: EQM  ) but formerly was a unit of EQT Corp. (NYSE: EQT  ) -- they talked, but nothing was signed. However, an EQT employee later that year thought that it had and began crediting gas to the wrong company.

• [By Michael Flannelly]

  Goldman Sachs analysts started coverage on EQT Midstream Partners LP (EQM) early on Monday, giving the oil and natural gas distribution company a bullish rating due to its low-risk cash flows.

  The analysts rate EQM as “Buy” and see shares reaching $59. This price target suggests a 22% upside to the stock’s Friday closing price of $48.28.

  Goldman Sachs analyst Theodore Durbin said, “EQM’s FERCregulated pipeline and storage assets offer stable, low-risk fee-based cash flows supported by firm long-term contracts. A robust production outlook in the Marcellus and meaningful inventory of dropdown assets at the parent enhances distribution growth visibility. EQM has a low cost of capital, no debt outstanding, high liquidity and an aligned sponsor that should bolster the partnership�� multi-year double-digit distribution growth outlook.”

  EQT Midstream Partners shares were inactive during pre-market trading on Monday. The stock is up 54.99% year-to-date.

• [By Lee Jackson]

  EQT Midstream Partners L.P. (NYSE: EQM) has everything the Oppenheimer team is looking for: low-risk, fee-based contracts in an attractive region, low financial leverage, high distribution growth and coverage and a supportive parent with assets to sell. Oppenheimer has a $55 price target for the stock. The Thomson/First Call estimate is at $54. Investors are paid a 3.4% distribution which Oppenheimer thinks may grow to 4.3% in 2014. Remember, MLP distributions may include return of principal.

Top Biotech Stocks To Own For 2014

Popular Posts: 10 Best “Strong Buy” Stocks ��EQM DAL BITA and more7 Biotechnology Stocks to Buy NowHottest Utilities Stocks Now – FE EXC NRG AEP Recent Posts: Biggest Movers in Utilities Stocks Now – ATO TRGP NI CIG 4 Aerospace and Defense Stocks to Buy Now 5 Stocks With Crummy Operating Margin Growth ��NBIX CTEL TSRA NYNY PMFG View All Posts

This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.

Top 5 Cheap Stocks To Own Right Now: Prosensa Holding NV (RNA)

Prosensa Holding N.V., formerly Prosensa Holding B.V., is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating (RNA)-modulating, therapeutics for the treatment of genetic disorders. The Company�� primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington�� disease. The Company�� clinical portfolio of RNA-based product candidates is focused on the treatment of Duchenne muscular dystrophy (DMD). The Company�� platform technology allows the development of RNA-modulating therapeutics that either interferes with splicing (exon skipping, exon inclusion, or splice mutation correction), remove mutant RNA, or block RNA expression, for different indications.

DMD is a rare, severe muscle wasting disease that occurs in up to 1 in 3,500 male births. It is commonly diagnosed between the ages of three to five, when boys begin to show signs of impaired motor development. PRO044, the Company�� product candidate, addresses a separate sub-population of DMD patients. The Company developed PRO044 using its exon-skipping technology to generate a product candidate with the same mechanism of action that is used by drisapersen.

Advisors' Opinion:

• [By Keith Speights]

  Successful launch
  You couldn't even buy stock in Prosensa (NASDAQ: RNA  ) just a few weeks ago. The biotech launched its IPO on June 28. To say that launch has gone successfully is an understatement. Shares are now more than double the IPO price and climbed 41% this week.

• [By John Udovich]

  It should also be mentioned that earlier in the week, GlaxoSmithKline plc (NYSE: GSK) returned full rights of Duchenne muscular dystrophy drug drisapersen to their partner�Prosensa Holding NV (NASDAQ: RNA) and that news sent shares down 12.48% on�Monday. Moreover,�Prosensa Holding also sank some 70% last fall when Drisapersen failed a phase 3 trial by missing a primary endpoint measuring for how far patients could walk over the course of six minutes (the improvement�wasn't significantly better than the placebo).�However, Prosensa Holding also rose 24.37% yesterday after announcing�initial findings from further analyses from the aggregate data for drisapersen, with the CEO saying:

• [By Sean Williams]

  Shares of Sarepta climbed to a 52-week high of $55.61 in September shortly after an experimental rival drug, drisapersen, developed by Prosensa (NASDAQ: RNA  ) and GlaxoSmithKline (NYSE: GSK  ) , missed its primary end point by a mile in late-stage trials. However, Sarepta also tanked just weeks later after the Food and Drug Administration decided against supporting an accelerated drug approval for eteplirsen; the agency would not make the connection that increased dystrophin production led to its remarkable trial results.�Also, given the recent failure of drisapersen in a phase 3 study, the FDA felt it pertinent that Sarepta engage in a broader study. Shares ultimately dipped as low as $12.12.�

• [By Sean Williams]

  What: Shares of Prosensa (NASDAQ: RNA  ) , a clinical-stage developer of RNA-modulating therapeutic agents for genetic disorders, jumped as much as 50% after reporting additional clinical findings on drisapersen at the JPMorgan Healthcare Conference.

Top Biotech Stocks To Own For 2014: Intrexon Corp (XON)

Intrexon Corporation, incorporated on April 19, 2004, is engaged in the business of synthetic biology. Using the Company�� suite of complementary technologies, it design, build and regulate gene programs, or sequences of deoxyribonucleic acid (DNA) that control cellular function, and cellular systems, or activities that take place within a cell and the interaction of those systems in the greater cellular environment, to enable the development of new and improved products and manufacturing processes across a variety of end markets, including healthcare, food, energy and environmental sciences. Its technologies include the UltraVector gene design and fabrication platform; Cell Systems Informatics; LEAP-cell identification and selection, and mAbLogix-antibody discovery.

The Company�� LEAP technology facilitates the automated identification of an individual cell with the highest levels of expression, quality and potency from a population of over 100,000 cells. Its mAbLogix platform complements UltraVector with a library of human antibodies that exceeds 500 million. By immortalizing human tonsils, which consists of lymphatic tissue containing B-cells, its mAbLogix platform creates a B-cell library that can generate antibodies against an almost infinite number of new antigens.

The UltraVector gene design and fabrication platform

The Company�� gene program design platform, which it refer to as UltraVector, is an integrated suite of tools comprising advanced DNA construction technology and components, cellular and protein engineering tools, computational models and statistical methods which facilitate the rapid design, build and testing of complex systems. The UltraVector platform allows the Company to translate gene programs into standard components that can be designed, manufactured and tested in an automated format. This technology enables it to engineer at the cellular level from biological sources.

UltraVector DNA design is computer-automated and ! utilizes a set of defined construction rules to assemble components that are stored in its DNA library. In addition to the number of gene components in its UltraVector library, it is designing and creating enzymatic and regulatory components that provide control over genome integration and gene regulation. Its RheoSwitch Therapeutic System is a three-component transcriptional regulator that provides inducible gene expression. The RheoSwitch Therapeutic System provides the ability to not only express proteins/enzymes of interest, but also the ability to control the level and timing of expression to achieve a biological outcome. Other ongoing programs include its Attsite recombinases, which mediate predictable gene exchange into host cells thereby eliminating many of the difficulties seen with traditional gene insertion.

Cell Systems Informatics

The Company�� Cell systems informatics permits design, as well as testing and learning about new gene targets or product pathways. Its bioinformatics software and database systems for mapping cellular pathways when combined with its genome-scale modeling and experimental data, including, gene expression profiling and protein engineering, enable the Company to optimize selection and development of gene programs and cellular systems for its collaborators. Its computational modeling and simulation platform enables the development of predictive computer models of organisms, from microbes to humans. This platform builds virtual cells from their basic molecular components, and can simulate the activity of the cell�� complete reaction network.

The Company is designing proteins with post-translational modifications. It is also working to develop enzyme inhibitors and fusion proteins for a variety of applications in human and animal therapeutics. Its protein engineering may utilize one or more of its technologies to obtain catalysis activitiesits component library, the generation of component variants sequence, evolutionary analy! sis and s! tructure-based sequence alignment, computer-aided drug discovery, de novo, or synthesized or generated, and comparative protein modeling, molecular dynamics simulation and free energy analysis, antibody design and humanization, antigenicity prediction, protein pharmacokinetics optimization, and/or in silico support of enzyme engineeringand quantitative structure-function relationships with machine learning algorithms to optimize, facilitate and prioritize protein variant libraries for the advancement of its collaborators.

LEAP-cell identification and selection

The Company�� Laser-Enabled Analysis and Processing technology (LEAP), is an instrument that merges semiconductor manufacturing technologies for cell processing applications to provide high levels of control and scale to cell purification and stem cell culture management. The LEAP platform can identify and purify cells of interest from large libraries of cells created by its UltraVector and bioinformatics technologies using a laser-based purification process, thereby providing a mechanism of testing the degree of protein expression in genetically modified cells, as well as means to learn from the genetic building process.

mAbLogix- antibody discovery

The Company�� mAbLogix antibody discovery platform, or mAbLogix platform, enables production of B-cell libraries for discovery of antibodies. The mAbLogix platform permits antigen targeting using fully human monoclonal and polyclonal antibodies. Its mAbLogix antibody discovery process consists of two major activities: the build of human B-cell libraries expressing a large number of antibodies, and the testing of these libraries based on an analysis of B-cells that express antibodies in response to a chosen antigen.

The Company competes with AbD SeroTec, Alexion Pharmaceuticals, Inc., XOMA Corporation, Genmab US, Inc., MorphoSys AG, NovImmune SA, Societe Des Systemes Biologiques, Adimab, LLC, ProMab Biotechnologies, Inc., Abpro, Inc.,! AIIM The! rapeutics and Open Monoclonal Technology, Inc.

Advisors' Opinion:

• [By John Udovich]

  Bubble talk, biotech IPO setbacks plus news�about small cap biotechs like Intrexon Corp (NYSE: XON) and TNI BioTech (OTCMKTS: TNIB) have dominated biotech news this week or in recent weeks. Just consider the following news:

• [By Ben Levisohn]

  Overvalued companies include MWI Veterinary (MWIV) and�Stericycle (SRCL), while companies with attractive valuations include Cardinal Health (CAH), Selected Medical (SEM). He’s not a fan of Intrexon (XON) but calls�Aratana (PETX) a “hidden gem.”

• [By Jon C. Ogg]

  Intrexon Corp. (NYSE: XON) was started as Buy at Mizuho Securities, started as Equal Weight at Barclays and started as Overweight at J.P. Morgan.

  Nokia Corp. (NYSE: NOK) was raised to Hold from Sell at Deutsche Bank, raised to Neutral from Underperform at Credit Suisse and
  Canaccord Genuity raised its price target to $5.50 from $3.30.

Top Biotech Stocks To Own For 2014: Rexahn Pharmaceuticals Inc (RNN)

Rexahn Pharmaceuticals, Inc. (Rexahn) is a development-stage biopharmaceutical company. The Company focuses on the development of cures for cancer to patients worldwide. The Company�� pipeline features one drug candidate in Phase II clinical trials. The Company also has several other drug candidates in pre-clinical development. In addition, the Company has two renal cell carcinoma (CNS) candidates, Serdaxin, CNS Disorders drug for depression and neurodegenerative diseases and Zoraxel, which is a erectile dysfunction (ED) and sexual dysfunction drug that are in clinical stages and the Company is are exploring options for further development . The Company�� drug candidate, Archexin is an anticancer Akt inhibitor.

Archexin

Archexin is potent inhibitor of the Akt protein kinase (Akt) in cancer cells. Archexin has FDA orphan drug designations for five cancers (RCC, glioblastoma, and cancers of the ovary, stomach and pancreas). Multiple indications for other solid tumors can also be pursued. Archexin inhibit both activated and inactivated forms of Akt, and to reverse the drug resistance observed with the protein kinase inhibitors. Archexin is an antisense oligonucleotide (ASO) compound that is complementary to Akt mRNA, and selective for inhibiting mRNA expression and production of Akt protein. As of December 31, 2011, Archexin was in Phase II clinical trials for the treatment of pancreatic cancer with enrollment completed in September, 2011.

Serdaxin

Serdaxin is an extended release formulation of clavulanic acid, which is an ingredient present in antibiotics approved by the FDA. The Company had been developing Serdaxin for the treatment of depression and neurodegenerative disorders. From January to September, 2011, the Company conducted a randomized, double-blind, placebo-controlled study compared two doses of Serdaxin, 0.5 milligram and 5 milligram, to placebo over an eight-week treatment period for major depressive disorder (MDD) patients. As of Dec! ember 31, 2011, the Company had not made a determination of Serdaxin�� future paths or resource allocations to further develop Serdaxin to treat MDD.

Zoraxel

Zoraxel is an orally administered, on-demand tablet to treat sexual dysfunction. Zoraxel is a dual enhancer of neurotransmitters in the brain that play a key role in sexual activity phases of motivation and arousal, erection and release, and may be the ED drug to affect all three of these phases of sexual activity. As of December 31, 2011, the Company was evaluating how to proceed with the Phase IIb study of Zoraxel.

The Company�� Pre-clinical Pipeline Drug Candidates includes RX-1792, which is a small molecule anticancer EGFR inhibitor; RX-5902, which is a small molecule anticancer ribonucleic acid (RNA) helicase regulator; RX-3117, which is a Small molecule anticancer deoxyribonucleic acid (DNA) synthesis Inhibitor; RX-8243, which is a small molecule anticancer aurora kinase inhibitor; RX-0201-Nano, which is a nanoliposomal anticancer Akt inhibitor; RX-0047-Nano, which is an nanoliposomal anticancer HIF-1 alpha inhibitor and RX-21101, which is a nano-polymer Anticancer.

Advisors' Opinion:

• [By Roberto Pedone]

  One under-$10 biopharmaceutical player that's just starting to move into breakout territory is Rexahn Pharmaceuticals (RNN), which is engaged in the development of novel treatments for cancer to patients. This stock has been on fire so far in 2013, with shares up sharply by 62%.

  If you take a look at the chart for Rexahn Pharmaceuticals, you'll notice that this stock has been uptrending strong for the last month, with shares moving higher from its low of 36 cents per share to its intraday high of 53 cents per share. During that uptrend, shares of RNN have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of RNN into breakout territory above some near-term overhead resistance levels at 49 cents to 50 cents per share. It's worth noting that volume today is tracking in extremely strong with over 3 million shares traded, versus its three-month average action of 1.22 million shares.

  Traders should now look for long-biased trades in RNN if it manages to break out above Thursday's intraday high of 53 cents per share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.22 million shares. If that breakout hits soon, then RNN will set up to re-test or possibly take out its next major overhead resistance levels at 64 cents to its 52-week high at 66 cents per share. Any high-volume move above 66 cents to 67 cents per share could then send RNN towards its next major overhead resistance levels at 81 cents per share.

  Traders can look to buy RNN off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average at 47 cents per share. One can also buy RNN off strength once it clears 53 cents per share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top Biotech Stocks To Own For 2014: Biodel Inc (BIOD)

Biodel Inc. (Biodel), incorporated on December 3, 2003, is a development-stage speciality biopharmaceutical company focused on the development and commercialization of treatments for diabetes. The Company develops its product candidates by applying its formulation technologies to existing drugs. Its advanced program involves developing formulations of injectable recombinant human insulin (RHI). In addition to its ultra-rapid-acting insulin formulations, the Company has developed prototype formulations of a liquid glucagon, a basal insulin and a glucose responsive insulin, in each case for use by patients with diabetes. RHI-based formulation known as Linjeta was the subject of a New Drug Application (NDA).

The Company has two pivotal Phase III clinical trials with its preferred commercial formulation of Linjeta prior to re-submitting the NDA. In August 2011, it completed patient visits and analyzed top-line data from the first Phase 1 clinical trial of two RHI-based formulations. The trial was a single-center, randomized, double-blind, three-period crossover trial in 18 subjects with Type 1 diabetes. The purpose of the trial was to evaluate the pharmacokinetic and pharmacodynamic characteristics and injection site toleration of BIOD-105 and BIOD-107, as compared to the insulin analog marketed as Humalog. The Company conducted Phase I, Phase II and Phase III clinical trials comparing the performance of its Linjeta formulation of RHI to either Humulin, which is a branded formulation of RHI or Humalog. Its pivotal Phase III clinical trials were open-label, parallel group, randomized trials conducted at centers in the United States, Germany and India.

The Company competes with Eli Lilly, Novo Nordisk, Sanofi-Aventis, Halozyme Therapeutics, Inc. and MannKind Corporation.

Advisors' Opinion:

• [By Monica Gerson]

  Biodel (NASDAQ: BIOD) is expected to post a Q1 loss at $0.24 per share.

  First Majestic Silver (NYSE: AG) is estimated to post its Q1 earnings at $0.10 per share on revenue of $63.35 million.

• [By Roberto Pedone]

  One under-$10 specialty biopharmaceutical player that's starting to trend within range of triggering a big breakout trade is Biodel (BIOD), which is focused on the development and commercialization of innovative treatments for diabetes. This stock has been hit hard by the bears over the last three months, with shares down by 24%.

  If you take a look at the chart for Biodel, you'll notice that this stock is ripping higher here right off its 50-day moving average of $2.32 a share with strong upside volume. Volume on Thursday has so far registered over 750,000 shares, which is well above its three-month average action of 445,084 shares. This move is quickly pushing shares of BIOD within range of triggering a big breakout trade.

  Traders should now look for long-biased trades in BIOD if it manages to break out above some near-term overhead resistance levels at $2.52 to $2.60 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 445,084 shares. If that breakout triggers soon, then BIOD will set up to re-test or possibly take out its next major overhead resistance levels $3 to its 200-day moving average of $3.39 a share. Any high-volume move above $3.39 will then give BIOD a chance to tag $4 a share.

  Traders can look to buy BIOD off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $2.10 a share. One can also buy BIOD off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top Biotech Stocks To Own For 2014: Chromadex Corp (CDXC)

Chromadex Corporation, incorporated on June 19, 2008, is a provider of research and quality-control products and services to the natural products industry. The Company�� products are used by customers worldwide in the dietary supplement, food and beverage, cosmetic and pharmaceutical industries. The Company together with its subsidiaries supplies phytochemical reference standards, which are small quantities of plant-based compounds used to research an array of potential attributes, and reference materials, related contract services, technical consulting and ingredients. On December 3, 2012, ChromaDex Inc. acquired Spherix Consulting Inc. The Company�� principal subsidiaries include ChromaDex, Inc., Chromadex Analytics, Inc. and Spherix Consulting, Inc (Spherix).

The Company provides its clients in the food, supplement and pharmaceutical industries with solutions to manage potential health and regulatory risks. Its science-based solutions are for both new and existing products that may be subject to product liability and/or exposed to changing scientific standards or public perceptions; literature evaluations, and design and assessment of pre-clinical and clinical safety testing. It specializes in regulatory submissions for food and dietary supplement ingredients. For its clients involved in drug development within the pharmaceutical industry, the Company provides similar services, as well as risk-based strategies, including intellectual property data and compliance gap identification, due diligence assessments and investigational new drug writing.

Products and Services

The Company offers bulk raw materials for inclusion in dietary supplements, food, beverage and cosmetic products. Through its catalog, it supplies a range of products necessary to conduct quality control of raw materials and consumer products. The Company through Chromadex Analytics, provides a range of contract services ranging from routine contract analysis for the production of dietary sup! plements, cosmetics, foods and other natural products to elaborate contract research for clients in these industries. The Company provides a range of consulting services in the areas of regulatory support, new ingredient or product development, risk management and litigation support. With an addition of Spherix, it provides regulatory approval and scientific advisory services.

The Company competes with Sigma-Aldrich, Phytolab, US Pharmacopoeia, Extrasynthese, Covance, Eurofins, and Silliker Canada Co.

Advisors' Opinion:

• [By Peter Graham]

  Small cap stocks Chromadex Corp (OTCMKTS: CDXC) and 22nd Century Group Inc (OTCBB: XXII) are, one way or the other, focused on natural products and have been getting some extra attention lately. Moreover, one of these stocks have been the subject of a disclosed investor awareness campaign. Keeping that in mind, are these two small cap stocks natural winners for investors? Here is a quick look:

Top Biotech Stocks To Own For 2014: PTC Therapeutics Inc (PTCT)

PTC Therapeutics, Inc., incorporated on March 31, 1998 , is a biopharmaceutical company focused on the discovery and development of orally administered, small-molecule drugs that target post-transcriptional control processes. The Company�� lead product candidate includes ataluren, which is used for the treatment of patients with genetic disorders that arise from a type of genetic mutation known as a nonsense mutation. Ataluren is in late stage clinical development for the treatment of Duchenne muscular dystrophy caused by nonsense mutations (nmDMD) and cystic fibrosis caused by nonsense mutations (nmCF).

Ataluren is orally administered small-molecule compound that targets nonsense mutations. The Company is engaged in the development of ataluren for the treatment of genetic disorders in, which a nonsense mutation is the cause of the disease. Genetic tests are available for many genetic disorders, including Duchenne muscular dystrophy and cystic fibrosis, to determine if the underlying cause is a nonsense mutation. The EMA has designated ataluren as an orphan medicinal product for the treatment of nmDMD and nmCF. During the year ended December 31, 2012, the Phase III clinical trial completed. The Company�� Ataluren clinical trials in patients with nonsense mutation genetic disorders include Ataluren for nmDMD: Phase 2b clinical trial complete; Confirmatory Phase III clinical trial initiated, and Ataluren for nmCF: Phase III trial completed.

Advisors' Opinion:

• [By WWW.DAILYFINANCE.COM]
  Records fell on Wall Street Friday as another solid report on housing lifted the market for the second day in a row. There's a three-day weekend coming up -- something that often prompts investor caution -- but the gains were broad-based even though volume was fairly light. The VIX, which measures volatility, fell to its lowest level this year. The Dow Jones industrial average (^DJI) gained 63 points, the Nasdaq composite (^IXIC) rose 31, and the Standard & Poor's 500 index (^GPSC) added 8, topping the record high set last week. The Dow Transportation average also raced to an all-time high, lifted by airline stocks. United (UAL) soared more than 4 percent; Delta (DAL) gained more than 1 percent and Southwest (LUV) gained 2 percent. Southwest is at an all-time high, up 79 percent from a year ago. New home sales bounced back with a better than expected 6.4 percent increase last month. Lennar (LEN) and D.R. Horton (DHI) both rose 4 percent. Pulte (PHM), Beazer (BZH) and Hovnanian (HOV) also solid posted gains. Earnings continue to drive retail stocks. Gap (GPS) edged higher even though net fell. Foot Locker (FL) gained 1½ percent after topping expectations. GameStop (GME) rose 4 percent. Its net rose, helped by the rollout last year of new Xbox and PlayStation consoles. Zumiez (ZUMZ) rose 5½ percent on an earnings beat. But Aeropostale (ARO) tumbled 24 percent. Its loss widened and sales declined. The retailer continues to struggle with teen fashion trends. Also on the earnings front, TiVo (TIVO) rose 2 percent as it swung to a profit from a year ago loss. It also reported an increase in the number of subscribers. Hewlett-Packard (HPQ) rose 6 percent on news the company plans to eliminate up to 16,000 additional workers in an effort to cut costs. And several stocks extended big moves from yesterday. Best Buy (BBY) rose more than 3 percent for the second straight day after earnings beat expectations. Isis Pharmaceuticals (ISIS) jumped
• [By John Kell]

  PTC Therapeutics Inc.(PTCT) said the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a negative opinion on the biopharmaceutical company’s marketing authorization application for its muscular dystrophy treatment. Shares slumped 21% to $20.60 in premarket trading.

Top 5 Canadian Companies To Watch For 2014

If you look through some explanations of why the Dow Jones Industrials (DJINDICES: ^DJI  ) failed to set a new record today, you'll find a common theme: Investors are worried about a potential correction. Yet the problem with that hypothesis is that investors have been worried about a correction for months now, if not years, and the market hasn't hesitated to climb higher regardless. With a decline of just 19 points for the Dow and similarly insignificant declines for the broader market, reading too much into the day's activity will lead you to false conclusions about what in reality isn't any change in sentiment among investors.

Moreover, focusing too much on pessimistic sentiment will distract you from pockets of optimism within certain sectors. For instance, Alcoa (NYSE: AA  ) climbed 1.7% today as investors continued to applaud the company's decision last week to shut down two of its Canadian production lines and to delay the construction of a new line for at least six years. With aluminum prices remaining stubbornly weak, Alcoa's move at the Baie-Comeau smelter in Quebec represents the latest in a series of strategic decisions designed to reduce overall supply and support long-term price increases for the metal. Even though it will take time for conditions to improve, Alcoa has demonstrated its willingness to make tough decisions in order to put itself in the best position to benefit from favorable long-term trends toward greater future use of aluminum.

10 Best Penny Stocks For 2015: 3M Company(MMM)

3M Company, together with subsidiaries, operates as a diversified technology company worldwide. The company?s Industrial and Transportation segment offers tapes, coated and non-woven abrasives, adhesives, specialty materials, filtration products, energy control products, closure systems for personal hygiene products, acoustic systems products, and components and products that are used in the manufacture, repair, and maintenance of automotive, marine, aircraft, and specialty vehicles. Its Health Care segment provides medical and surgical supplies, skin health and infection prevention products, inhalation and transdermal drug delivery systems, dental and orthodontic products, health information systems, and food safety products. The company?s Display and Graphics offers optical film solutions for LCD electronic displays; computer screen filters; reflective sheeting for transportation safety; commercial graphics sheeting and systems; and mobile interactive solutions, includin g mobile display technology, visual systems products, and computer privacy filters. The company?s Consumer and Office segment provides office supply products, stationery products, construction and home improvement products, home care products, protective material products, certain consumer retail personal safety products, and consumer health care products. Its Safety, Security and Protection Services segment offers personal protection products, safety and security products, cleaning and protection products for commercial establishments, track and trace solutions, and roofing granules for asphalt shingles. The company?s Electro and Communications segment provides packaging and interconnection devices; fluids that are used in the manufacture of computer chips, and for cooling electronics and lubricating computer hard disk drives; high-temperature and display tapes; insulating materials, including tapes and resins; and related items. The company was founded in 1902 and is based in St. Paul, Minnesota.

Advisors' Opinion:

• [By Marc Bastow]

  Companies ramped up for the holiday this week with a slew of dividend increases, as we headed into what is a traditionally a slow period between Christmas and New Year’s. Blue-Chip stocks in particular started handing out dividend sweets early, with aerospace and defense giant Boeing (BA) upping its dividend 50%, while manufacturing conglomerate 3M (MMM) raised its payout by 35%.

Top 5 Canadian Companies To Watch For 2014: Vanguard Natural Resources LLC(VNR)

Vanguard Natural Resources, LLC, through its subsidiaries, engages in the acquisition and development of oil and natural gas properties in the United States. Its properties are located in the southern portion of the Appalachian Basin, primarily in southeast Kentucky and northeast Tennessee; the Permian Basin, primarily in west Texas and southeastern New Mexico; and south Texas. As of December 31, 2010, the company had estimated proved reserves of 69.3 million barrels of oil equivalent, as well as working interests in 2,270 net productive wells. Vanguard Natural Resources, LLC was founded in 2006 and is based in Houston, Texas.

Advisors' Opinion:

• [By Matt DiLallo]

  Vanguard Natural Resources (NASDAQ: VNR  )
  Clocking in at No. 2 with a five-year compound annual growth rate of 172% is Vanguard Natural Resources. The company started with just 67 billion cubic feet equivalent of mainly natural gas reserves in Kentucky and Tennessee back in 2007. Today, the company has 175 million barrels of oil equivalent reserves spread across nine operating areas.

• [By Matt DiLallo]

  Two-thirds of the reserves are located in the midcontinent, which are well-known for holding great MLP-type assets that have long life and low decline. Peers like LINN Energy (NASDAQ: LINE  ) and Vanguard Natural Resources (NASDAQ: VNR  ) each has a substantial presence in the midcontinent region. Eagle Rock's reserves there have a heavy natural gas component; gas is 64% of these reserves. However, Eagle Rock has an exciting oil play in the region, which I'll get to in a moment.

• [By Matt DiLallo]

  Last year Vanguard Natural Resources (NASDAQ: VNR  ) changed its distribution policy and in so doing changed the game for oil and gas producing MLPs. The new monthly distribution policy enabled the company's income-seeking investors to better match their monthly cash outflows with monthly inflows from Vanguard. It was such a unique strategy that the company even trademarked the tag line that the company is "The Monthly Distribution MLP."

Top 5 Canadian Companies To Watch For 2014: Advantage Oil & Gas Ltd (AAV)

Advantage Oil & Gas Ltd. and its subsidiaries engage in the acquisition, exploitation, development, and production of oil and gas in the provinces of Alberta and Saskatchewan, Canada. It produces and sells crude oil, natural gas, sulphur, and natural gas liquids primarily through marketing companies. As of February 5, 2013, the company�s core properties comprised of Glacier Montney natural gas asset with approximately 80 net sections of land located in Alberta. Advantage Oil & Gas Ltd. was founded in 2001 and is headquartered in Calgary, Canada.

Advisors' Opinion:

• [By Stephan Dube]

  Comparing the netbacks with its peers, we can see that MEG Energy reported Q2 operating netbacks of $41.93/Boe, Advantage Oil & Gas' (AAV) Q2 operating netbacks totaled $14.74/Boe, Baytex has realized $25.76/Boe for Q1 and Bonavista Energy operating netbacks for Q1 amounted to $19.49/Boe. Therefore, with an average netback of $26.11/Boe, BlackPearl's $28.65/Boe is a little higher than the average of its peers with higher realized prices and stronger recoveries.

• [By Eric Lam]

  Royal Bank gained 1.2 percent as the market value of the nation�� largest lender rose past C$100 billion for the first time. Bankers Petroleum Ltd. and Advantage Oil & Gas Ltd. (AAV) climbed more than 2.7 percent as oil companies advanced. H&R Real Estate Investment Trust and Canadian Apartment Properties REIT added at least 2.5 percent to pace gains among financial stocks. Athabasca Oil Corp. tumbled 9.9 percent after an Alberta court decided to allow an aboriginal group to appeal an approval of the company�� Dover oil-sands project.

• [By John Udovich]

  While Bakken formation oil and gas stocks have grabbed the attention of�American investors, small cap Alberta or Saskatchewan oil and gas stocks Advantage Oil & Gas Ltd (NYSE: AAV), Sonde Resources Corp (NYSEMKT: SOQ) and up and coming Centor Energy Inc (OTCBB: CNTO) have been largely overlooked as they seek to exploit oil and gas (including oil sands) in the resource rich Canadian provinces of Alberta or Saskatchewan or seek strategic alternatives for their assets in these areas or themselves. It should be mentioned that Canada�� oil reserves are third only to Venezuela and Saudi Arabia with over 95% of these reserves being the oil sands of Alberta plus that province contains much of the country�� conventional oil reserves as well. In addition, the province of Saskatchewan along with offshore areas of Newfoundland contain substantial production and reserves. Excluding oil sands, Alberta would have 39% of Canada�� remaining conventional oil reserves,�followed by�offshore Newfoundland with�28% and Saskatchewan with 27%.

Top 5 Canadian Companies To Watch For 2014: MagnaChip Semiconductor Corporation (MX)

MagnaChip Semiconductor Corporation designs and manufactures analog and mixed-signal semiconductor products for high-volume consumer applications. It operates in three segments: Display Solutions, Power Solutions, and Semiconductor Manufacturing Services. The Display Solutions segment offers source and gate drivers, and timing controllers that cover a range of flat panel displays used in liquid crystal displays (LCDs), light emitting diodes (LEDs), 3D and organic light emitting diode televisions and displays, notebooks, and mobile communications and entertainment devices. The Power Solutions segment develop, manufactures, and markets power management solutions, including metal oxide semiconductor field effect transistors, power modules, analog switches, LED drivers, DC-DC converters, voice coil motor drivers, and linear regulators. This segment offers its products for a range of devices, including LCD, LED, 3D televisions, smartphones, mobile phones, desktop PCs, notebooks , tablet PCs, and other consumer electronics, as well as for industrial applications, such as power suppliers, LED lighting, and home appliances. The Semiconductor Manufacturing Services segment manufactures various products comprising display drivers, LED drivers, audio encoding and decoding devices, microcontrollers, touch screen controllers, RF switches, park distance control sensors for automotives, electronic tag memories, and power management semiconductors. This segment offers semiconductor manufacturing services to fabless analog and mixed-signal semiconductor companies. MagnaChip Semiconductor Corporation provides its products and services to consumer electronics OEMs, subsystem designers, and contract manufacturers through a direct sales force, as well as through a network of authorized agents and distributors in the United States, Korea, Taiwan, China, Japan, Hong Kong, and Macau. The company is headquartered in Seoul, South Korea.

Advisors' Opinion:

• [By Wallace Witkowski]

  Shares of MagnaChip Semiconductor Corp. (MX) �fell 13% to $12.50 on moderate volume after the company said it incorrectly stated revenue and has to restate its financial statements going back to 2011. Also, the company withdrew its guidance for the fourth quarter.

• [By Brian Pacampara]

  Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, consumer gadget chip maker MagnaChip Semiconductor (NYSE: MX  ) has earned a coveted five-star ranking.

Top Performing Companies To Invest In Right Now

Top Performing Companies To Invest In Right Now: iShares Russell 3000 Index Fund (IWV)

iShares Russell 3000 Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the Russell 3000 Index (the Index). The Index measures the performance of the United States equity market. The Index serves as the underlying index for Russell 3000 Growth and Value Series, and the Russell 1000 and Russell 2000 Indexes, as well as their respective Growth and Value series. The Index is a capitalization-weighted index and consists of the 3000 largest companies domiciled in the United States and its territories.

The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. iShares Russell 3000 Index Fund's investment advisor is Barclays Global Fund Advisors.

Advisors' Opinion:

• [By John Maxfield]

  Over the past five years, this ETF has beaten the Dow Jones Industrial Average (DJINDICES: ^DJI  ) by 23 percentage points. It's outperformed the Russell 3000 (NYSEMKT: IWV  ) by 21 percentage points. And it's done the same to the eponymous S&P 500, exceeding it by 11 percentage points.

source from Top Stocks For 2015:http://www.topstocksblog.com/top-performing-companies-to-invest-in-right-now-2.html

10 Best Stocks To Invest In Right Now

Core-satellite investing is a method of portfolio construction designed to minimize costs, tax liability and volatility while providing an opportunity to outperform the broad stock market as a whole. The core of the portfolio consists of passive investments that track major market indices, such as the Standard and Poor's 500 Index (S&P 500). Additional positions, known as satellites, are added to the portfolio in the form of actively managed investments. Read on to find out how this works.

Portfolio Construction
First, look at the core portion of your portfolio. The assets will be allocated to investments that are designed to be managed passively. For example, you could put half of the assets dedicated to stocks into an index fund that tracks the S&P 500.

For the actively managed portion, the goal is to select investments where a portfolio manager's skill provides an opportunity to earn greater returns than those generated by the passive portion of the portfolio. In this example, you could put 10% of the portfolio into a high-yield bond fund and divide the remaining stock portion evenly between a biotechnology fund and a commodities fund. The asset allocation might break down as shown in Figure 1 below.

5 Best Media Stocks To Buy For 2015: Electro-Sensors Inc.(ELSE)

Electro-Sensors, Inc. engages in the manufacture and distribution of industrial production monitoring and process control systems; and the development and distribution of PC-based software for automated survey processing and hand printed character recognition. Its Production Monitoring Division manufactures and sells various monitoring systems that measure actual machine production and operation rates, as well as systems that regulate the speed of related machines in production processes. This division?s products comprise speed monitoring systems, including a line of digital products, which translate sensor impulses from its production monitoring systems into digital readouts indicating production counts or rates, such as parts, gallons, or board feet; alarm systems, tachometers, and other devices that translate impulses from the sensors into alarm signals, computer inputs, or digital displays; and drive control system products, which monitor machine operation levels and r egulate the speed of motors on related machines in a production sequence. It serves grain, feed, biofuels, food processing, chemicals, agricultural, mining, utility, forest products, steel, tire, glass, and electronics industries. This division sells its products through home office sales force, manufacturer?s representatives, and distributors in the United States, Mexico, China, Canada, Peru, Chile, Bolivia, Colombia, Thailand, Israel, Malaysia, Singapore, the Great Britain, and South Africa. The company?s AutoData Systems Division designs and markets desktop software based systems that read handprinted characters, checkmarks, and bar code information from scanned or faxed forms, as well as collects and reports data from Web forms. This division markets its products primarily through home office sales personnel, as well as through value-added resellers in the United States, Canada, and western Europe. Electro-Sensors, Inc. was founded in 1968 and is based in Minnetonka, Min nesota.

Advisors' Opinion:

• [By victorselva]

  The current dividend yield is 3.1% outperforming not just the industry average (1.91%), but also the company Electro-Sensors, Inc. (ELSE) with a 3% dividend yield. So dividends are considered good to protect the purchasing power and might attract investors, because is a good option for them to receive cash while they are waiting for more upside appreciation.

10 Best Stocks To Invest In Right Now: Western Refining Inc.(WNR)

Western Refining, Inc. operates as an independent crude oil refiner and marketer of refined products. The company operates in three segments Refining Group, Wholesale Group, and Retail Group. The Refining Group segment operates two refineries in Texas and Mexico; two stand-alone refined product distribution terminals in New Mexico; and four asphalt terminals in Texas, as well as operates crude oil transportation and gathering pipeline system in New Mexico. It refines various grades of gasoline, diesel fuel, jet fuel, and other products from crude oil, other feedstocks, and blending components; and acquires refined products through exchange agreements and from various third-party suppliers. This segment sells its products through its wholesale group and service stations, independent wholesalers and retailers, commercial accounts, and sales and exchanges with oil companies. The Wholesale Group segment distributes commercial wholesale petroleum products primarily in Arizona, California, Colorado, Nevada, New Mexico, Texas, and Utah for retail fuel distributors, as well as for the mining, construction, utility, manufacturing, transportation, aviation, and agricultural industries. The Retail Group segment operates service stations, which include convenience stores or kiosks that sell various grades of gasoline, diesel fuel, general merchandise, and beverage and food products to the general public. As of February 24, 2012, it operated 210 service stations with convenience stores or kiosks located in Arizona, New Mexico, Colorado, and Texas. The company was incorporated in 2005 and is headquartered in El Paso, Texas.

Advisors' Opinion:

• [By John Reese]

  Indeed, in 2013, the Greenblatt-based portfolio has bounced back strong, returning more than 50%. Below is a look at its current holdings.

  EBIX, Inc. (EBIX)
  
  Western Refining (WNR)
  
  DirecTV (DTV)
  
  ITT Educational Services (ESI)
  
  Science Applications International (SAIC)
  
  Weight Watchers International (WTW)
  
  ConocoPhillips (COP)
  
  AmSurg Corp. (AMSG)
  
  PDL BioPharma (PDLI)
  
  AFC Enterprises (AFCE)
  
  

  Subscribe to Validea here��/p>

• [By Igor Greenwald]

  Western Refining (WNR) operates refineries in El Paso, Texas, and Gallup, New Mexico, with a combined throughput capacity of 153,000 barrels per day.

• [By Eric Volkman]

  Western Refining (NYSE: WNR  ) investors are about to find a few more coins in their pockets. The company has declared a Q3 dividend of $0.18 per share, to be paid on Aug. 15 to shareholders of record as of July 31. That amount is exactly 50% higher than Western Refining's previous disbursement of $0.12, which was handed out in early May.

10 Best Stocks To Invest In Right Now: Joe's Jeans Inc.(JOEZ)

Joe?s Jeans Inc. designs, produces, and sells apparel and apparel-related products worldwide. Its product line comprises women?s and men?s denim jeans, pants, shirts, sweaters, jackets, and other apparel products under the Joe?s brand. The company also offers women?s handbags and clutches, shoes, belts, and leather goods under various license agreements. In addition, it provides children?s products consisting of denim bottoms, tops, T-shirts, and jackets for infants, toddlers, girls, and boys. The company sells its products to various retailers, including department stores, specialty stores, and distributors, as well as through its retail stores; and through the Internet site, joesjeans.com/shop. As of November 30, 2011, it operated 17 outlet stores and 5 full price retail stores. The company was formerly known as Innovo Group Inc. and changed its name to Joe?s Jeans Inc. in October 2007. Joe?s Jeans Inc. was founded in 1987 and is based in Commerce, California.

Advisors' Opinion:

• [By Monica Gerson]

  Joe's Jeans (NASDAQ: JOEZ) is estimated to post its Q3 earnings at $0.02 per share on revenue of $33.37 million.

  Linear Technology (NASDAQ: LLTC) is projected to post its Q1 earnings at $0.46 per share on revenue of $339.26 million.

• [By Rick Munarriz]

  Friday
  Things are usually quiet on Fridays, but that won't stop Joe's Jeans (NASDAQ: JOEZ  ) from reporting. The premium denim specialist should benefit from strong growth in luxury apparel. As the economy continues to bounce back, we're finding fewer people flinching at paying $300 for a pair of jeans.

• [By Rick Munarriz]

  Shares of Joe's Jeans (NASDAQ: JOEZ  ) were slammed today after posting disappointing quarterly results.

  The retailer of high-priced denim clocked in with roughly half of the revenue growth that Wall Street was targeting. Declining profitability also missed the mark.

• [By Rick Munarriz]

  Luxury retail has been popular at this stage of the economic recovery, and we'll find out a bit more when Joe's Jeans (NASDAQ: JOEZ  ) reports quarterly results after Monday's market close.

10 Best Stocks To Invest In Right Now: G-III Apparel Group Ltd (GIII)

G-III Apparel Group, Ltd. (G-III) designs, manufactures and markets a range of apparel, including outerwear, dresses, sportswear, women�� suits and women�� performance wear, as well as luggage and women�� handbags, small leather goods and cold weather accessories. It operates in three segments: wholesale licensed products, wholesale non-licensed products and retail operations. The wholesale licensed products segment includes sales of products under brands licensed by it from third parties. The wholesale non-licensed products segment includes sales of products under its own brands and private label brands. The retail operations segment consists almost entirely of the operations of its Wilsons outlet stores. The Company sells its products under its own brands, which include Andrew Marc, Marc New York and Marc Moto, licensed brands and private retail labels. In August 2012, the Company acquired Vilebrequin, a provider of swimwear, accessories and resort-wear. Effective November 4, 2013, G-III Apparel Group Ltd acquired GH Bass & Co.

The Company provides apparel under recognized brands to a cross section of retailers, such as Macy��, Bloomingdale��, Nordstrom, Lord & Taylor, The Bon-Ton Stores, Dillards, JC Penney, Belk and Kohl��. As of January 31, 2012, the Company operated 139 retail stores, of which 135 are outlet stores operated under the Wilsons Leather name and four are outlet stores operated under its Andrew Marc brand. It has licenses to produce branded fashion apparel under the Calvin Klein, Kenneth Cole, Cole Haan, Guess?, Tommy Hilfiger, Levi��, Dockers, Jessica Simpson, Ellen Tracy, Kensie, Mac & Jac, Jones New York, Sean John and Nine West brands, among others. It also has sports licenses with the National Football League, National Basketball Association, Major League Baseball, National Hockey League, Touch by Alyssa Milano and over 100 United States colleges and universities. G-III sells outerwear, dresses and handbags under the Company�� own Andrew Marc, Marc ! New York and Marc Moto brands and has licensed these brands to select third parties in certain product categories. Its other owned brands include, among others, Jessica Howard, Eliza J, Black Rivet, G-III, G-III Sports by Carl Banks and Winlit.

The Company works with a group of retailers, such as JC Penney, Kohl�� and Express in developing private label product lines. G-III�� products are sold primarily to department, specialty and mass merchant retail stores in the United States. It sells to approximately 2,400 customers, ranging from national and regional chains to small specialty stores. It also distributes its products through its retail outlet stores. It also markets its products in Canada, Europe and the Far East.

G-III�� branded apparel also consists of both women�� and men�� products. The Andrew Marc line of women�� and men�� luxury apparel is sold to upscale department and specialty retail stores. The Marc New York line of women�� and men�� better priced outerwear is sold to upper tier stores. The Marc Moto line is a men�� denim lifestyle collection of sportswear and accessories. The Jessica Howard label is a moderate price dress line that sells to department stores, specialty stores and catalogs. Eliza J is a better dress line that sells to better department and specialty stores. The Black Rivet line of apparel consists of women�� and men�� outerwear. It sells men�� sports-related apparel under its G-III Sports by Carl Banks label.

Advisors' Opinion:

• [By Amal Singh]

  G-III Apparel (NASDAQ: GIII  ) has a strong portfolio of 30 licensed brands, marketing apparel, outerwear, beachwear, luggage, women's handbags, small leather goods, and accessories, to name a few of its products. The company sells its apparel�offerings under popular brand names like Andrew Marc, Jessica Howard, Calvin Klein, Levi's, and Tommy Hilfiger. The company has also announced plans to revive the Starter Statin jacket franchise�. It is also looking at acquisitions and mergers to grow its business moving forward�.

10 Best Stocks To Invest In Right Now: Ocado Group PLC (OCDO)

Ocado Group plc is a United Kingdom-based holding company. The Company�� principal activities are the retailing, logistics and distribution of grocery and consumer goods and the development and monetisation of intellectual property and technology for the online retailing, logistics and distribution of these goods. The Company is an online grocery retailer. The Company�� subsidiaries include Ocado Holdings Limited, Ocado Limited, Ocado Information Technology Limited, Last Mile Developments Limited and Last Mile Developments Limited. Advisors' Opinion:

• [By Sarah Jones]

  Rio Tinto Group and Anglo American Plc (AAL) retreated more than 2.5 percent as copper and lead declined. Eurasian Natural Resources Corp. (ENRC) sank 6.8 percent as analysts downgraded the shares. Standard Life Plc slipped 1.2 percent as Chief Financial Officer Jackie Hunt resigned to move to a rival insurer. Ocado Group Plc (OCDO) fell for the first day this week as the online grocer ruled out a takeover by William Morrison Supermarkets Plc.

10 Best Stocks To Invest In Right Now: GTx Inc.(GTXI)

GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions. The company markets FARESTON (toremifene citrate) 60 mg tablets for the treatment of metastatic breast cancer in postmenopausal women primarily through wholesale drug distributors in the United States. It is developing selective androgen receptor modulators (SARMs), including Ostarine (GTx-024), which has completed Phase II clinical trial for the prevention and treatment of muscle wasting in patients with non-small cell lung cancer; and CapesarisTM (GTx-758), a selective estrogen receptor alpha agonist that has completed Phase IIa clinical trial for the first line treatment of advanced prostate cancer. In addition, the company is developing estrogen receptor beta agonists and other novel compounds that are in preclinical development stage for the treatment of metabo lic diseases, ophthalmic diseases, cancer, psoriasis, and/or pain. The company was founded in 1997 and is headquartered Memphis, Tennessee.

Advisors' Opinion:

• [By Keith Speights]

  War of words
  In the stock market, the old saying that "sticks and stones may break my bones, but words can never hurt me" doesn't hold water. GTx (NASDAQ: GTXI  ) investors experienced that reality firsthand this week, with shares dropping 15% from an online article published on Wednesday.

• [By Roberto Pedone]

  One biopharmaceutical player that's rapidly moving within range of triggering a major breakout trade is GTx (GTXI), which is dedicated to the discovery, development and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle loss and other serious medical condition. This stock has been hammered by the bears so far in 2013, with shares off sharply by 53%.

  If you look at the chart for GTx, you'll notice that this stock recently gapped down sharply from over $4 to below $1.50 a share with heavy downside volume. Following that gap down, shares of GTXI have rebounded sharply and started to uptrend, with the stock moving higher from its low of $1.31 to its recent high of $1.96 a share. During that move, shares of GTXI have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of GTXI within range of triggering a major breakout trade.

  Traders should now look for long-biased trades in GTXI if it manages to break out above some near-term overhead resistance at $1.96 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.35 million shares. If that breakout triggers soon, then GTXI will set up to re-fill some of its previous gap down zone from August that started just above $4 a share. Some possible upside targets if GTXI gets into that gap with volume are $2.50 to $3 a share, or possibly even $3.50 a share.

  Traders can look to buy GTXI off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $1.50 a share. One can also buy GTXI off strength once it takes out $1.96 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By John Udovich]

  Cancer has been one of the hotter segments of the sizzling biotech sector this year with small cap cancer stocks�Genetics Inc (NASDAQ: CGIX), GTx, Inc (NASDAQ: GTXI) and MetaStat Inc (OTCMKTS: MTST) being among those involved in cancer research or treatment producing noteworthy news for investors to digest. Just consider the following:

• [By James E. Brumley]

  If you were lucky enough to step into Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) when your truly suggested it was a budding buy back on December 23rd, then congratulations - you're now up a little more than 60% (assuming you bought into RNN after the break above a key resistance line on the 27th). Now get out. Instead, use your profits from the Rexahn to take on a stake in GTx, Inc. (NASDAQ:GTXI). No, GTXI may not look like much at first, but when you take a step back and look at a chart of GTx, Inc. through a longer-term lens, the upside potential becomes clear.

10 Best Stocks To Invest In Right Now: Progress Energy Inc.(PGN)

Progress Energy, Inc., a utility holding company, engages in the generation, transmission, distribution, and sale of electricity in North Carolina, South Carolina, and Florida. It uses coal, oil, hydroelectric, natural gas, and nuclear power to generate electricity. The company also engages in various alternative energy projects to generate electricity from swine waste and other plant or animal sources, biomass, solar, hydrogen, and landfill-gas technologies. Progress Energy serves various industries, including chemicals, textiles, paper, food, metals, wood products, rubber and plastics, and stone products, as well as phosphate rock mining and processing, electronics design and manufacturing, and citrus and other food processing. It has approximately 22,000 megawatts of regulated electric generation capacity and serves approximately 3.1 million retail electric customers, as well as other load-serving entities. The company was formerly known as CP&L Energy, Inc. Progress En ergy, Inc. was founded in 1925 and is headquartered in Raleigh, North Carolina.

Advisors' Opinion:

• [By Holly LaFon] ess Energy shares climbed over 2011 as the company announced in January it would merge with Duke Energy. Together, they will form the nation�� largest utility with a combined enterprise value of $65 billion and $37 billion in market cap. The new company will have 57 gigawatts of domestic generating capacity through a mix of coal, nuclear, natural gas, oil and renewable resources. Progress energy shareholders will receive an approximately 3 percent dividend increase.

  Incidentally, development of a comprehensive energy policy was one of what Grantham called ��he most important and most dangerous issues��facing the world.

  Progress is at the forefront of the push for nuclear energy in the U.S., which has been deemed the ��uclear renaissance.��Thirty-five percent of the electricity used by Progress Energy customers comes from one of their four nuclear sites, two in North Carolina, and one each in South Carolina and Florida. It plans to build another reactor in Levy County, Florida.

  Revenue at Progress Energy has declined at a 2.6% annual rate over the past five years, and it achieved cash flow of $95 million in 2010, after three years of losses. Earnings have remained positive, reaching a record for the decade of $856 million in 2010.

  RSC Holdings (RRR)

  RSC is a machinery rental service for construction, industrial, petrochemical, governmental and manufacturing businesses in the U.S. and Canada. RSC tends to benefit in economic downturns, as more businesses turn to renting rather than buying equipment to cut costs. Rented equipment rose 20.7% percent (the sixth consecutive quarter of double-digit growth) and rental revenue increased 27% in the fourth quarter of 2011, compared to last year.

  United Rentals (URI), one of RSC�� largest competitors, had a rental revenue increase of 18.5% in the fourth quarter compared to last year, which included a 6.7% increase in rental rates.

  The company�� fleet utilization also

Top 10 Canadian Stocks To Own For 2015

Top 10 Canadian Stocks To Own For 2015: (AMC)

AMC Entertainment Holdings, Inc., through its subsidiaries, operates as a theatrical exhibition company in the United States and internationally. As of June 30, 2011, it owned, operated, or had interests in 357 theatres and 5,098 screens in 31 states and the District of Columbia, and 4 countries outside the United States. The company was founded in 1920 and is headquartered in Kansas City, Missouri. As of August 30, 2012, AMC Entertainment Holdings, Inc. operates as a subsidiary of Dalian Wanda Group Corporation Ltd.

Advisors' Opinion:

• [By Brian Nichols]

  Thanks to visionaries like Steve Jobs, Jeff Bezos, Reed Hastings, and Larry Page, the way we view, interact, and process data has changed and this includes all of the major industries within technology and entertainment. Today, it's a mobile world, yet the one industry that remains unchanged is very much the movie industry. According to DreamWorks Animation (NASDAQ: DWA  ) CEO Jeffrey Katzenberg, this could spell trouble, especially for the likes of Carmike Cinemas (NASDAQ: CKEC  ) , Regal Entertainment (NYSE: RGC  ) , and AMC Entertainment Holdings (NYSE: AMC  ) .

• [By Rick Aristotle Munarriz]

  Frederic J. Brown, AFP/Getty Images Moviegoers aren't heading out the multiplex the way they used to, but that doesn't mean that Hollywood is toast. AMC Entertainment (AMC) reported quarterly results Tuesday. The nation's leading exhibitor -- 345 theaters with 4,976 screens -- went public two months ago. The headline numbers are positive. Revenue increased a better than expected 2.3 percent to $713 million. Profitability also expanded nicely. However, revenue increased as a result of a 5.5 percent increase in ticket prices and a 3.7 percent uptick in concessions purchased by patrons. Obviously you don't see those k! ind of gains against a mere 2.3 percent lift in revenue without dealing with more empty seats, and that's just what happened. There was a 3.2 percent decline in attendance. AMC's ticket takers welcomed 50.4 million guests during the holiday quarter, well below the 52.1 million guests that it entertained a year earlier. That's bad, and what makes things worse is that it had fewer theaters -- from continuing operations -- a year earlier. It wouldn't be wise to hold out for a Hollywood ending. Customers Want Bigger and Better Things Apologists will argue that it wasn't a bumper crop of movies hitting theaters, but that's not accurate at all. Last year's biggest box office winner -- "The Hunger Games: Catching Fire" -- opened in November. Disney's "Frozen" also opened ahead of the holidays, and it's the family entertainment giant's biggest non-Pixar earner since 1994's "The Lion King." Moviegoers still come out for the big movies, and they're also willing to pay more for a premium setting. IMAX (IMAX) reported blowout quarterly results a few days earlier. IMAX screens rang up a record $244 million in ticket sales worldwide. IMAX is also closing out the year with a record backlog of 384 commercial theaters to deploy. RealD (RLD) is also holding up nicely as a leading provider of 3-D systems for exhibitors. It enjoyed a major boost with "Gravity," a

• [By Rick Aristotle Munarriz]

  Getty Images From a popular multiplex operator going public to a retailer getting hacked at the worst possible time, here's a rundown of the week's best and worst news from the business world. Chipotle Mexican Grill (CMG) -- Winner Chipotle is getting a new stamp in its ethnic cuisine passport. Having mastered Mexican, it was already giving Asian a shot with its new ShopHouse chain. And now, we can add Italian to its map after Chipotle revealed this week that it's a financial backer of Pizzeria Locale. The fast casual concept gives pizza a Chipotle-like makeover with folks ordering at the counter, customizi! ng their ! 11-inch pies along the assembly line, after which they are baked in a speedy oven that serves up tasty pies in just two minutes. Chipotle's growing just fine with its flagship burrito chain, but it never hurts to diversify before expansion-fueled growth plateaus, or tastes change. Target (TGT) -- Loser Holiday shopping at Target may ultimately prove to more trouble than bargain seekers were hoping for this season. The cheap chic discounter revealed that hackers installed software that stole the info on more than 40 million credit and debit card transactions from Nov. 27 through Dec. 15. This is naturally going to be bad news for those that had their plastic compromised. Everyone that shopped at Target this season is being advised to carefully look over their statements. However, it's also very bad for the retailer at the worst possible time. Shoppers may not be too comfortable heading into Target during these last few shopping days before Christmas. AMC Entertainment (AMC) -- Winner Lights! Camera! IPO action! It may not have been the blockbuster IPO of the year, but the debut of the leading movie theater chain proved to be a success this week. AMC Entertainment went public at $18, opening 7 percent higher and staying above its IPO price. The leading exhibitor operates 343 movie theaters housing 4,950 screens. AMC entertains 200 million guests

• [By DailyFinance Staff]

  The looming Fed taper has been the talk of Wall Street for months, but it still came as a surprise to investors when it actually happened. Stocks rallied Wednesday following the Fed's decision to cut its $85 billion a month purchase of bonds by $10 billion, beginning in January. Outgoing Fed Chairman Ben Bernanke said the economy continues to "make progress." The Dow Jones industrial average (^DJI) soared 292 points on the news, its third biggest one-day gain this year. The Dow also hit a closing high, as did the Standard & Poor's 500 index (^GPSC), which gained 29 points. And the Nasdaq composite (^IXIC) ros! e 46 poin! ts. Consider it Bernanke's final present to the market before he retires from his position atop the Fed. Among the big blue chip winners, 3M (MMM) rose 3 percent, while Exxon Mobil (XOM), Chevron (CVX) and Goldman Sachs (GS) all rose 2 percent. But Microsoft (MSFT) was flat, reflecting across the board weakness in tech stocks. Many of the biggest players on the Nasdaq lost ground despite the overall market rally. Apple (AAPL) and Twitter (TWTR) ended lower and Tesla (TSLA) lost nearly 3 percent. Part of the reason for the tech weakness was an earnings miss and a weak forecast from Jabil Circuits (JBL), a key maker of electronics. Its shares plunged 20 percent. But homebuilders were strong following a report showing that housing starts last month rose to highest level in nearly six years. Lennar (LEN), which also posted strong earnings, jumped 6 percent. William Lyon Homes rose 4 percent, KB Homes (KBH) and Toll Brothers (TOL) each rose 3.5 percent. Ford (F) shares skidded more than 6 percent after lowering its profit forecast for next year. The company also warned that it may not meet its target for 2015 and 2016. In part, Ford blames the high expenses tied its planned launch of a record number of new vehicles next year. Finally, the movie theater chain AMC Entertainment (AMC) rose 5 percent from its $18 a share IPO price. This is exp

source from Top Stocks For 2015:http://www.topstocksblog.com/top-10-canadian-stocks-to-own-for-2015.html

Best Consumer Companies To Watch For 2015

Best Consumer Companies To Watch For 2015: China New Borun Corporation (BORN)

China New Borun Corporation, through its subsidiaries, engages in the production and distribution of corn-based edible alcohol in the People's Republic of China. Its edible alcohol products are primarily sold as ingredients to producers of baijiu, which a grain-based alcoholic beverage to further blend them into finished products that are sold under various brand names in retail stores, bars, banquet halls, restaurants, and other locations. The company also produces distillers dried grains with solubles (DDGS) feed, corn germ, crude corn oil, and liquid carbon dioxide as by-products during the production of edible alcohol. The company was founded in 2000 and is based in Shouguang, the People's Republic of China. China New Borun Corporation is a subsidiary of King River Holding Limited.

Advisors' Opinion:

• [By James E. Brumley]

  With a market cap of only $60 million and practically no trading volume until last month, odds are good you and most of your trading friends have ever even heard of China New Borun Corp. (NYSE:BORN). That doesn't mean it can't become a good trading opportunity, however. In fact, BORN has become a good trading opportunity, especially this week.

source from Top Stocks For 2015:http://www.topstocksblog.com/best-consumer-companies-to-watch-for-2015.html

Advanced Cannabis Solutions Temporarily Gets CANN-ed

Related FULL 3 Unique Income Investments Stocks Hitting 52-Week Highs Related CANN 3 Things That Could Extinguish The 'Reefer Rally' How Would a Hypothetical Marijuana ETF Do This Year?

Advanced Cannabis Solutions (OTC: CANN) was suspended from trading Thursday morning by the Securities and Exchange Commission.

An SEC report questioned the Colorado based company, inquiring about the possibility of undisclosed affiliates and shareholders unlawfully distributing securities.

As a result, shares of CANN are suspended until April 9, 2014.

In an email to Benzinga, CANN CFO Christopher Taylor said that "the management of the company [is] as shocked as anyone," further noting that "this does not pertain to any of the restricted shares owned by the founders or officers.

"This relates to stock that has been sold that is free trading, and we have no control over these sales."

See also: 14 Cannabis Stocks To Watch In 2014

420 Investor Alan Brochstein called CANN "one of the best companies in the [cannabis] space," noting that this is most likely a third-party problem with an individual investor breaking the rules.

Brochstein also pointed out that when other cannabis companies have had trade halted (AVNE, CDFT, and PTOG), the SEC provided incredibly vague reports regarding the suspensions, while the report for CANN has very specific language.

Full Circle Capital (NASDAQ: FULL), a business development firm that has significant investments in CANN, is trading down today on the news of the suspension.

FULL has paid CANN $500,000 in warrants, which is part of a $30 million dollar senior secured convertible note purchase agreement.

In addition to the CANN news, FULL paid a monthly dividend of .067 per share on March 14, and is trading ex dividend thursday.

At the time of publication, FULL was trading down 16.71 percent.

Posted-In: 420 investor cannabis marijuana SECNews Emerging Markets Movers & Shakers Politics Legal Economics Markets General Best of Benzinga

© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  Most Popular UPDATE: BofA Announces $4B Buyback Plan, Raises Qtr. Dividend from $0.01 to $0.05/Share UPDATE: Facebook to Acquire Oculus VR for About $2B Advanced Cannabis Solutions Temporarily Gets CANN-ed Federal Reserve Board announces approval of capital plans of 25 bank holding companies participating in the Comprehensive Capital Analysis and Review Spotify Vs. Pandora Vs. Google Music Vs. iTunes Radio Vs. Xbox Music UPDATE: Bank of America Announces Settlements With Federal Housing Finance Agency (FHFA) and New York Attorney General Related Articles (FULL + CANN) Advanced Cannabis Solutions Temporarily Gets CANN-ed 3 Things That Could Extinguish The 'Reefer Rally' How Would a Hypothetical Marijuana ETF Do This Year? 3 Unique Income Investments Around the Web, We're Loving...